Phase III EGCG clinical trial at Mayo in Limbo

[Guest guest]

Dr. Neil Kay of the Mayo Clinic who did the Phase I and II

clinical trials of Epigallocatechin gallate (EGCG) and CLL,

reported to Schorr of Patient Power in a video

interview, that the company that made the highly pure form

of EGCG, Polyphenon E, (Mitsui Norin Co., Ltd. of Japan) has

decided they will not proceed further with a Phase III

clinical trial in CLL patients, but will concentrate their

efforts on solid tumour cancers.

Dr. Kay, suggests that EGCG could perhaps be used in

combination with other drugs and they continue to work to

see if clinical trials in combination with other treatments

may be possible in the future.

Source: Patient Power Video:

http://www.patientpower.info/video/can-green-tea-ecgc-or-vitamin-d-help-fight-cl\

l

or

http://tinyurl.com/6b5x3pf